Insider Transactions in Q2 2023 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2023
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
7,555
+50.0%
|
-
|
|
Jun 02
2023
|
Laurie Stelzer Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,647
-5.49%
|
$171,939
$37.06 P/Share
|
|
May 24
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
619
-0.5%
|
$27,855
$45.29 P/Share
|